关键词：
adult males cohort study febuxostat gout flares initial introduction of urate-lowering therapy.
摘要：
Objectives: Frequent gout attacks in the initial introduction of urate-lowering therapy are significant causes of poor drug adherence and ULT discont...
作者：
Yuejiao Wang, Xue Wang, Chaoqi Du, Zeming Wang, Jiahui Wang, Nan Zhou, Baohua Wang, Ke Tan, Yumei Fan, Pengxiu Cao
（
Affiliations 1 Ministry of Education Key Laboratory of Molecular and Cellular Biology, Hebei Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology, College of Life Sciences, Hebei Normal University, Hebei Research Center of the Basic Discipline of Cell Biology, Hebei Collaborative Innovation Center for Eco-Environment, Shijiazhuang, Hebei, China. 2 Department of Laboratory, Hebei Provincial People's Hospital, Shijiazhuang, Hebei, China. 3 Department of Gynecology, Xingtai People's Hospital, Xingtai, Hebei, China. 4 Department of Thoracic Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
）
出处：
Frontiers in endocrinology 2024 Vol.15
P1379521
摘要：
At present, pulmonary fibrosis is a prevalent and irreversible lung disease with limited treatment options, and idiopathic pulmonary fibrosis is one...
摘要：
Circular RNAs are reported to be involved in the tumorigenesis of lung adenocarcinoma . Here, this study focused on studying the function and mechani...
摘要：
Metadherin , initially discovered in primary astrocytes of the human fetus through rapid subtraction hybridization and labeled as astrocyte elevated g...
作者：
Juntao Yin, Wan Wang, Zhiliang Fan, Lixin Guo
（
Affiliations 1 Department of Neurology, Xingtai Central Hospital, Xingtai, China. 2 Department of Neurology, Hebei Medical University Affiliated Hospital: Xingtai people's Hospital, Xingtai, China. 3 Department of Cardiac Surgery, Xingtai Central Hospital, Xingtai, China.
）
作者：
Ruoqi Han, Yanqi Ma, Zhikun Liu, Chunxiao Li, Sainan Li, Xiangshun Kong, Meng Han, Yueping Liu, Cuizhi Geng
（
Affiliations 1 Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. 2 Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. 3 Department of Radiotherapy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. 4 Department of Breast Surgery, Xingtai People's Hospital, Xingtai, China. 5 Department of Breast Surgery, The First Hospital of Qinhuangdao, Qinhuangdao, China.
）
出处：
Translational breast cancer research : a journal focusing on translational research in breast cancer 2022 Vol.3
P24
关键词：
Ki-67 Residual disease in breast and nodes neoadjuvant chemotherapy prognosis residual disease in breast and nodes combined with Ki-67 .
摘要：
Background: The accurate assessment of residual tumor tissue after neoadjuvant chemotherapy for breast cancer is closely related to the subsequent tr...
作者：
Tengfei Liu, Fei Yang, Junli Qiao, Mengxuan Mao
（
Affiliations 1 Department of Head and Neck Thyroid Surgery, Xingtai People's Hospital of Hebei Medical University, Xingtai, P.R. China. 2 Department of Otorhinolaryngology - Head and Neck Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, P.R. China.
）
出处：
Medicine 2024 Vol.103 No.20
Pe38059
摘要：
This study aims to dissect the evolution and pivotal shifts in Fine-Needle Aspiration research for thyroid nodules over the past 2 decades, focusing ...
作者：
HARMONi-A Study Investigators
，
Wenfeng Fang, Yuanyuan Zhao, Yongzhong Luo, Runxiang Yang, Yan Huang, Zhiyong He, Hui Zhao, Mingjun Li, Kai Li, Qibing Song, Xiaobo Du, Yulan Sun, Wei Li, Fei Xu, Zhiyu Wang, Kunning Yang, Yun Fan, Baogang Liu, Hongyun Zhao, Ying Hu, Li Jia, Shen Xu, Tienan Yi, Dongqing Lv, Haitao Lan, Mengxia Li, Wenhua Liang, Yongsheng Wang, Hui Yang, Yuming Jia, Yuan Chen, Junguo Lu, Jifeng Feng, Chunling Liu, Ming Zhou, Jianya Zhou, Xianling Liu, Ningning Zhou, Ming He, Xiaorong Dong, Hualin Chen, Yongxing Chen, Haichuan Su, Xiaoling Li, Zhihong Zhang, Lei Yang, Ying Cheng, Likun Chen, Xue Hou, Yu Zhang, Jun Guo, Zhen Wang, Hong Lu, Di Wu, Weineng Feng, Wen Li, Jianan Huang, Yan Wang, Xia Song, Jiewen Peng, Laiyu Liu, Yubiao Guo, Wenting Li, Dongmei Lu, Mingxiu Hu, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Li Zhang
（
Affiliations 1 Sun Yat-sen University Cancer Center, Guangzhou, China. 2 Hunan Cancer Hospital, Changsha, China. 3 Yunnan Cancer Hospital, Kunming, China. 4 Fujian Provincial Tumor Hospital, Fuzhou, China. 5 The Second Hospital of Anhui Medical University, Hefei, China. 6 The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. 7 Tianjin Medical University Cancer Institute & Hospital, Tianjin, China. 8 Renmin Hospital of Wuhan University, Wuhan, China. 9 Mianyang Central Hospital, Mianyang, China. 10 Shandong Cancer Prevention and Treatment Institute, Jinan, China. 11 The First Affiliated Hospital of Bengbu Medical University, Bengbu, China. 12 The First Affiliated Hospital of Nanchang University, Nanchang, China. 13 The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. 14 Weifang No. 2 People's Hospital, Weifang, China. 15 Zhejiang Cancer Hospital, Hangzhou, China. 16 Harbin Medical University Cancer Hospital, Harbin, China. 17 Beijing Chest Hospital, Capital Medical University, Beijing, China. 18 Yuncheng Central Hospital of Shanxi Province, Yuncheng, China. 19 Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou, China. 20 Xiangyang Central Hospital, Xiangyang, China. 21 Taizhou Municipal Hospital, Taizhou, China. 22 Sichuan Provincial People's Hospital, Chengdu, China. 23 Army Medical Center of Chinese People's Liberation Army, Chongqing, China. 24 The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. 25 West China Hospital of Sichuan University, Chengdu, China. 26 The Second Affiliated Hospital of Xiamen Medical College, Xiamen, China. 27 Yibin Second People's Hospital, Yibin, China. 28 Tongji Hospital of Tongji Medical College of Hust, Wuhan, China. 29 Nantong Tumor Hospital, Nantong, China. 30 Jiangsu Cancer Hospital, Nanjing, China. 31 Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China. 32 Affiliated Cancer Hospital and Institution of Guangzhou Medical University, Guangzhou, China. 33 The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. 34 The Second Xiangya Hospital of Central South University, Changsha, China. 35 Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China. 36 Affiliated Hospital of Guangdong Medical University, Guangzhou, China. 37 Hainan General Hospital, Haikou, China. 38 Tangdu Hospital of the Fourth Military Medical University, Xi'an, China. 39 Liaoning Cancer Hospital & Institute, Cancer Hospital of Dalian University of Technology, Shenyang, China. 40 Anhui Provincial Cancer Hospital, Hefei, China. 41 Gansu Provincial Cancer Hospital, Lanzhou, China. 42 Jilin Cancer Hospital, Changchun, China. 43 Nanjing Chest Hospital, Nanjing, China. 44 Xingtai People's Hospital, Xingtai, China. 45 Linyi Cancer Hospital, Linyi, China. 46 Huaihe Hospital of Henan University, Kaifeng, China. 47 Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital (First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University), Shenzhen, China. 48 The First People's Hospital of Foshan, Foshan, China. 49 The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China. 50 The First Affiliated Hospital of Soochow University, Suzhou, China. 51 General Hospital of Ningxia Medical University, Yinchuan, China. 52 Shanxi Cancer Hospital, Taiyuan, China. 53 Zhongshan City People's Hospital, Zhongshan, China. 54 Nanfang Hospital Nanfang Medical University, Guangzhou, China. 55 The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. 56 Akeso Biopharma, Inc, Zhongshan, China.
）
出处：
JAMA 2024
摘要：
Importance: For patients with non-small cell lung cancer whose disease progressed while receiving EGFR tyrosine kinase inhibitor therapy, particularl...
摘要：
Osteoarthritis and Rheumatoid Arthritis are significant health concerns with notable prevalence and economic impact. RA, affecting 0.5% to 1.0% of t...
作者：
Lina Zhang, Chengyu Liu, Xiaochong Zhang, Changjing Wang, Dengxiang Liu
（
Affiliations 1 Department of Health Examination Center, Xingtai People's Hospital, Xingtai, Hebei, 054001, China. 2 Graduate School of Hebei Medical University, Shijiazhuang, Hebei, 050000, China. 3 Key Laboratory of Cancer Prevention and Treatment, Xingtai People's Hospital, Xingtai, Hebei, 054001, China. 4 Department of Gastrointestinal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China. 5 Institute of Cancer Control, Xingtai People's Hospital, Xingtai, Hebei, 054001, China. rmyy666@163.com.
）
